retsevmo
eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - antineoplastické činidlá - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.
tisercin
egis pharmaceuticals plc, maďarsko - levomepromazín - 68 - antipsychotica (neuroleptica)
klaritromycin mylan 500 mg
mylan ireland limited, Írsko - klaritromycín - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)
maracex 20 mg/ml injekčný/infúzny roztok
as kalceks, lotyšsko - morfín - 65 - analgetica - anodyna
lusopress
istituto luso farmaco d´ italia s.p.a., taliansko - nitrendipín - 58 - hypotensiva
unipres 10
krka - nitrendipín - 58 - hypotensiva
unipres 20
krka - nitrendipín - 58 - hypotensiva
nitresan 10 mg
pro.med.cs praha a.s., Česká republika - nitrendipín - 58 - hypotensiva
nitresan 20 mg
pro.med.cs praha a.s., Česká republika - nitrendipín - 58 - hypotensiva
axura
merz pharmaceuticals gmbh - memantín hydrochlorid - alzheimerova choroba - Ďalšie lieky proti demencii - liečba pacientov so stredne ťažkým až ťažkým alzheimerovej choroby.